Close

Press Releases

Turkish Cargo Receives the IATA Smart Facility Operational Capacity Certification for its SMARTIST Facility at Istanbul Airport

Turkish Cargo, the air cargo brand of Turkish Airlines, has received the IATA Smart Facility Operational Capacity Certification. This prestigious certification, received for the SMARTIST Terminal, confirms that Turkish Cargoโ€™s operational procedures comply with IATA Regulations (IATA Cargo Handling...

Phastar named in 2024 Environment 100 List

Phastar, global specialist biometrics contract research organization (CRO), has been recognized in the 2024 Environment 100 List, led by Graham Clark. The award is further recognition of Phastarโ€™s commitment to being a purpose-led organization which is leading the CRO...

BIO Asia-Taiwan 2024 concludes successfully

Number of visitors and business opportunities reach new highs Inaugural BIO Asia Awards presented, and expansion of conference into three tracks highlight Taiwan as important partner for biotech development in Asia With the final day of the four-day BIO Asiaโ€“Taiwan 2024...

Recycle-ready blister film for food supplements

The market for food supplements is booming! Many people want more than just a healthy diet - which is why they are increasingly turning to so-called โ€œnutraceuticalsโ€, e.g. vitamin supplements. Manufacturers of food supplements need blister packaging to ensure the...

Authenticx Announces AI Solution Revolutionizing Adverse Event Reporting

Authenticx, the new standard in healthcare for listening at scale, today announced a next-generation solution and suite of AI models that can detect healthcare-specific reportable events. The innovative models revolutionize contact center operations and empower pharmacovigilance and patient safety...

At Pack Expo, MHI to Demo Small-batch Blister Machine for Stability Tests & Clinical Trials

Erie, CO โ€“ Maruho Hatsujyo Innovations (MHI) โ€“ the U.S. subsidiary of Maruho Hatsujyo Kogyo Co. Ltd, a Japanese company with subsidiaries in Asia and the U.S. will showcase a blister machine specifically intended for stability testing, clinical trials...

Abzena Supplies Clinical Trial Material for Angiex’s Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugateโ„ข (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial of AGX101, a first-in-class TM4SF1-directed Antibody-Drug Conjugate (ADC). Angiex partnered with Abzena, the leading end-to-end...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป